ROBO4

Chr 11AD

roundabout guidance receptor 4

Also known as: AOVD3, ECSM4, MRB

The ROBO4 protein functions as a receptor for Slit proteins and maintains endothelial barrier organization, playing a critical role in angiogenesis and vascular patterning. Mutations cause aortic valve disease 3, which follows autosomal dominant inheritance. The gene shows minimal constraint against loss-of-function variants (very low pLI score), suggesting the cardiovascular phenotype may involve specific functional alterations rather than simple protein loss.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Aortic valve disease 3MIM #618496
AD
0
Active trials
16
Pubs (1 yr)
17
P/LP submissions
6%
P/LP missense
0.91
LOEUF
LOF*
Mechanism· G2P
Clinical SummaryROBO4
🧬
Gene-Disease Validity (ClinGen)
aortic valve disease 3 · ADModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 134 VUS of 200 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.91LOEUF
pLI 0.000
Z-score 2.05
OE 0.67 (0.500.91)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.09Z-score
OE missense 0.99 (0.921.06)
591 obs / 597.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.67 (0.500.91)
00.351.4
Missense OE0.99 (0.921.06)
00.61.4
Synonymous OE0.91
01.21.6
LoF obs/exp: 30 / 44.8Missense obs/exp: 591 / 597.2Syn Z: 1.14
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
strongROBO4-related bicuspid aortic valve and aortic aneurysmLOFAD
DN
0.76top 25%
GOF
0.78top 25%
LOF
0.3452th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

200 submitted variants in ClinVar

Classification Summary

Pathogenic11
Likely Pathogenic6
VUS134
Likely Benign17
Benign9
Conflicting3
11
Pathogenic
6
Likely Pathogenic
134
VUS
17
Likely Benign
9
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
11
0
11
Likely Pathogenic
2
1
3
0
6
VUS
3
126
5
0
134
Likely Benign
0
10
1
6
17
Benign
0
4
1
4
9
Conflicting
3
Total51412110180

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ROBO4 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗